Pyrimidine Reverse Transcriptase Inhibitors for HIV Replication
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antiviral compounds for HIV infection are inadequate in effectively inhibiting HIV replication and preventing HIV-mediated diseases.
Innovation Solution
Development of novel pyrimidine-based compounds, including specific structures such as 02721614-((4-(2,6-Dimethylphenoxy)-6,7-dihydro-5H-cyclopenta[d]pyrimidine-2-yl)amino)-benzonitrile, which inhibit HIV-1 reverse transcriptase and can be used alone or in combination with other antiviral agents for treatment and prevention of HIV-mediated diseases.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current antiviral compounds are used for HIV treatment, then HIV replication is inhibited to some extent, but the inhibition effectiveness is insufficient
Solution Approach 1:
The patent modifies the chemical structure parameters of existing pyrimidine compounds by introducing specific substituents (R1, X1, X2, Y1, Rb groups) and structural variations (cyclopenta[d]pyrimidine core with different ring systems), thereby optimizing the biological activity and HIV replication inhibition effectiveness while managing structural complexity
Solution Approach 2:
The invention creates composite molecular structures by combining pyrimidine core with various heterocyclic systems (cyclopenta[d]pyrimidine, pyrido[4,3-d]pyrimidine, pyrimido[4,5-d]azepine) and substituent groups, forming complex but functionally optimized antiviral compounds with enhanced effectiveness
2Reliability
If novel pyrimidine-based compounds are developed to improve HIV inhibition, then therapeutic effectiveness increases, but development complexity and manufacturing difficulty increase
Solution Approach 1:
The patent divides the complex pyrimidine-based compounds into modular structural components (core pyrimidine ring, heterocyclic systems, and variable substituent groups R1, X1, X2, Y1, Rb), allowing independent optimization and simplifying the synthesis pathway planning for each segment
Solution Approach 2:
The invention develops a universal pyrimidine core structure that can accommodate multiple different substituent patterns and heterocyclic variations, enabling a single synthetic platform to produce multiple antiviral compounds with different specific activities and pharmacological profiles
Data Source
AI summary
Novel pyrimidine derivatives, as well as pharmaceutical compositions and drugs contained in them, capable of inhibiting HIV replication are presented. These novel pyrimidine compounds, as well as pharmaceutical compositions and drugs contained in them, are capable of treating and preventing HIV-mediated diseases. The treatment and/or prevention of HIV in subjects with HIV-infection (human immunodeficiency virus) or having risk of getting HIV-infection with the compounds and compositions is also presented.